Last reviewed · How we verify
NCT06969521: ORDER
Online Rotating Delivery of Perception/Production Enhanced Treatment for Rhotics
NA trial testing Visual acoustic biofeedback: ORDER in Speech Sound Disorder in 60 participants. Currently enrolling.
1 July 2027
Quick facts
| Lead sponsor | Montclair State University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 10 May 2025 |
| Primary completion | 1 July 2027 |
| Estimated completion | 1 July 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Visual acoustic biofeedback: ORDER
- Perception Training: ORDER
Conditions studied
- Speech Sound Disorder — all drugs for Speech Sound Disorder →
Sponsor
Montclair State University
Who can join
Adults 8 to 17, any sex, with Speech Sound Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to determine whether perceptual training enhances speech perception and production outcomes in children with Residual Speech Sound Disorders (RSSD). The main questions it aims to answer are: Does pre-treatment speech production accuracy predict treatment response? Does perceptual acuity influence the effectiveness of perception-first versus production-first interventions? Researchers will compare TAU+Perception-first and TAU-first treatment conditions to see if the order of intervention affects speech improvement outcomes, particularly based on participants' initial perception and production accuracy. Participants will: Complete pre-treatment evaluations to assess /r/ production and speech perception. Be grouped into high or low production and perception accuracy categories based on established thresholds. Be randomly assigned (using a blocked randomization procedure) to one of two treatment arms via telepractice. Participate in the assigned treatment condition designed to target speech sound accuracy. Randomization is stratified to ensure treatment groups are balanced based on pre-treatment severity in both the perception and production domains.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06969521
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Speech Sound Disorder
Currently open trials in the same condition.
- NCT06512168 — Measuring Aided Language Development · NA · recruiting
- NCT06884943 — Generalization With AI Navigation Using StaRt · Phase 2 · recruiting
- NCT05988515 — AI-Assisted Treatment for Residual Speech Sound Disorders · NA · recruiting
- NCT06517225 — Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial · Phase 2 · recruiting
- NCT06416306 — Treatment Targets in Spanish and English Bilingual Speech Intervention · Phase 1 · recruiting
Other Montclair State University trials
Trials by the same sponsor.
- NCT07344740 — Blood Flow Restriction Resistance Exercise and Cardiac Cycle Dynamics · NA · not yet recruiting
- NCT06645145 — Language Learning and Language Experience · NA · completed
- NCT06504264 — The Effect of Articulatory Gestures on Early Literacy Skills in 4-year Olds · NA · completed
- NCT04858035 — Auditory-Perceptual Training Via Telepractice · NA · completed
- NCT04858022 — Visual Acoustic Biofeedback for RSE Via Telepractice · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06969521 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Montclair State University
- Last refreshed: 29 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06969521.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing